Alexander Goldfarb

Education

• Ph.D. Central Institute Transplantation and Artificial Organs, Moscow, Russia (1988 — 1992)
• M.S. Udmurt State University (1982 — 1988)
• M.D. Izhevsk State Medical Academy (ISMA) (1980 — 1986)

Companies

• Senior Medical Director Inozyme Pharma (2020)
• Owner Personalized Medicine, LLC (2016)
• Lecturer Harvard Medical School (2007)
• Assistant Professor of Medicine Beth Israel Deaconess Medical Center (2007)
• Medical Director Akebia Therapeutics (2018 — 2020)
• Assistant Professor of Medicine University of Utah School of Medicine (2001 — 2007)
• Nephrology Fellow Stanford University (1999 — 2001)
• Medical Resident The New York Hospital Medical Center of Queens (1996 — 1999)